Natco Pharma’s Hyderabad division receives EIR from USFDA

18 Sep 2025 Evaluate

Natco Pharma’s Hyderabad pharma division has received Establishment Inspection Report (EIR) classifying the facility as Voluntary Action Indicated (VAI) from the U.S. Food and Drug Administration (USFDA). 

Earlier, U.S. Food and Drug Administration (USFDA) had conducted an inspection at its Pharma division located in Kothur, Hyderabad, India.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

908.10 -8.15 (-0.89%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×